T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.

MLA

Warren, E. H., et al. “T-Cell Therapy Targeting Minor Histocompatibility Ags for the Treatment of Leukemia and Renal-Cell Carcinoma.” Cytotherapy, vol. 4, no. 5, 2002, p. 441. EBSCOhost, https://doi.org/10.1080/146532402320776116.

APA

Warren, E. H., Tykodi, S. S., Murata, M., Sandmaier, B. M., Storb, R., Jaffee, E., Childs, R., Thompson, J. A., Greenberg, P. D., & Riddell, S. R. (2002). T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma. Cytotherapy, 4(5), 441. https://doi.org/10.1080/146532402320776116

Chicago

Warren, E H, S S Tykodi, M Murata, B M Sandmaier, R Storb, E Jaffee, R Childs, J A Thompson, P D Greenberg, and S R Riddell. 2002. “T-Cell Therapy Targeting Minor Histocompatibility Ags for the Treatment of Leukemia and Renal-Cell Carcinoma.” Cytotherapy 4 (5): 441. doi:10.1080/146532402320776116.